Article
HIV-negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A clinical retrospective investigation study from a National Tuberculosis Clinical Research Center
2022-02-07
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>China is the region with a high global burden of Rifampicin Resistance /Multidrug-Resistant tuberculosis (RR/MDR-TB) and low HIV incidence. Our aim was to assess the clinical and demographic characteristics of RR/MDR - extrapulmonary tuberculosis (EPTB) from 2015 to 2019, to provide evidence for the prevention and control of the disease in high TB burden areas.<...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1652cd68-8460-5a19-9fed-578b7586e799
- DOI
- 10.21203/rs.3.rs-636342/v2
